fixed dose combination of 300 mg netupitant and 0.5 mg palonosetron hydrochloride with a safety profile comparable to that of its single components. Netupitant is a neurokinin-1 receptor antagonist
this multi-center, prospective, non-comparative observational study, we evaluated the efficacy and safety profile of a probiotic food supplement, composed by a mixture of lactic acid bacteria and live ... dehydration…
small-cell lung cancer when combined with chemotherapy. However, its real-world effectiveness and safety profile require further evaluation. This retrospective study examines demographic characteristics, treatment…
metabolism, and excretion (ADME) properties in humans early in the development process, significantly enhancing safety profiling. By using non-toxic, minimal doses, microdosing aids in identifying the most appropriate…
personalized medicine, offering insights into how individual genetic differences can influence drug efficacy and safety profiles. Personalized medicine aims to tailor therapeutic interventions based on patients' genetic…
arthritis (RA), providing targeted interventions that significantly improve clinical outcomes. However, their long-term safety profile remains a crucial consideration for clinicians and patients alike. This article…
Conclusion: Based on this retrospective claims analysis, CIII buprenorphine may have a milder safety profile than oral CII opioids for cLBP treatment. Belbuca® seems to be better tolerated than
latest advances in biologic therapies for IBD, focusing on their efficacy and safety profiles. Recent biologics, including anti-TNF agents, integrin inhibitors and IL-12/23 inhibitors, have shown substantial
with conventional mitoxantrone, liposomal mitoxantrone hydrochloride (PLM60) has shown promising antineoplastic effect and better safety profiles in the previous studies, and worth a further evaluation on its…